HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Acquired Hypocalciuric Hypercalcemia

Also Known As:

Hypocalciuric Hypercalcemia, Acquired

Networked: 9 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Disease Context: Research Results

Nutritional and Metabolic Diseases: 15
- Metabolic Diseases: 10142
  - Water-Electrolyte Imbalance: 54
    - Hypercalcemia: 8166
      - Acquired Hypocalciuric Hypercalcemia: 9
  - Calcium Metabolism Disorders: 47
    - Hypercalcemia: 8166
      - Acquired Hypocalciuric Hypercalcemia: 9

Related Diseases

1.	Hypercalcemia (Milk Alkali Syndrome)
2.	Rare Diseases (Rare Disease)

Experts

1.	Iiri, Taroh: 4 articles (01/2019 - 03/2007)
2.	Makita, Noriko: 4 articles (01/2019 - 03/2007)
3.	Manaka, Katsunori: 2 articles (01/2019 - 03/2007)
4.	Sato, Junichiro: 2 articles (01/2019 - 03/2007)
5.	Brown, Edward M: 2 articles (12/2013 - 07/2004)
6.	Kaku, Kohei: 1 article (10/2021)
7.	Kamei, Shinji: 1 article (10/2021)
8.	Kaneto, Hideaki: 1 article (10/2021)
9.	Kimura, Tomohiko: 1 article (10/2021)
10.	Kohara, Kenji: 1 article (10/2021)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Acquired Hypocalciuric Hypercalcemia:

1.	AutoantibodiesIBA 12/01/2013 - "A calcimimetic is an effective treatment for the hypercalcemia and elevated PTH levels in acquired hypocalciuric hypercalcemia caused by inhibitory anti-CaSR autoantibodies. " 10/24/2022 - "Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies." 01/01/2019 - "The autoantibody-induced inactivation of the calcium-sensing receptor (CaSR) causes acquired hypocalciuric hypercalcemia (AHH). " 07/01/2017 - "Autoimmune lymphocytic parathyroiditis and acquired hypocalciuric hypercalcemia associated with autoantibodies against the calcium-sensing receptor (anti-CaSR) are rare and poorly understood conditions. " 05/10/2014 - "[Case report; A case of acquired hypocalciuric hypercalcemia due to autoantibody against the calcium-sensing receptor]."
2.	Calcium-Sensing ReceptorsIBA 01/01/2019 - "The autoantibody-induced inactivation of the calcium-sensing receptor (CaSR) causes acquired hypocalciuric hypercalcemia (AHH). " 07/01/2017 - "Autoimmune lymphocytic parathyroiditis and acquired hypocalciuric hypercalcemia associated with autoantibodies against the calcium-sensing receptor (anti-CaSR) are rare and poorly understood conditions. " 05/10/2014 - "[Case report; A case of acquired hypocalciuric hypercalcemia due to autoantibody against the calcium-sensing receptor]." 01/01/2014 - "The calcium-sensing receptor autoantibody that we have identified in the serum of a patient with acquired hypocalciuric hypercalcemia (AHH) is the first example of a biased allosteric modulator of a GPCR working in a pathophysiological context. " 03/27/2007 - "An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations."
3.	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/01/2014 - "Biased agonism: a novel paradigm in G protein-coupled receptor signaling observed in acquired hypocalciuric hypercalcemia."
4.	Prednisolone (Predate)FDA LinkGeneric 10/24/2022 - "Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies."
5.	AntibodiesIBA 07/01/2017 - "We present this patient in the context of the relevant published literature on lymphocytic parathyroiditis and acquired hypocalciuric hypercalcemia related to anti-CaSR antibodies. " 07/01/2017 - "Autoimmune lymphocytic parathyroiditis and acquired hypocalciuric hypercalcemia associated with anti-CaSR antibodies is a very rare yet important condition to be considered in a patient with acquired PTH-dependent hypercalcemia with inappropriate hypocalciuria. "
6.	Cinacalcet (Sensipar)FDA Link 10/22/2021 - "Amelioration of hypercalcemia by cinacalcet treatment in a subject with relapsing acquired hypocalciuric hypercalcemia: A case report."